Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
Sponsor: Hellenic Cooperative Oncology Group
Summary
GEMA-proN is an observational, multicenter, single cohort, retrospective clinical trial. The aim of the trial is to assess the prevalence, and prognostic value of genetic molecular alterations and investigate correlations with clinicopathological features in unselected patients with histologically confirmed non-small cell lung cancer (NSCLC).
Official title: Assessment of the Prevalence and Prognostic Value of Gene Molecular Alterations and Association With Clinicopathological Factors in Patients With Non-small Cell Lung Cancer (NSCLC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
367
Start Date
2013-09-09
Completion Date
2025-05-15
Last Updated
2025-05-23
Healthy Volunteers
No
Conditions
Locations (1)
Hellenic Cooperative Oncology Group (HeCOG)
Athens, Greece